Hakutulokset - Derk‐Jan A. de Groot

Tarkenna hakua
  1. 1
    Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: From lab to clinic

    Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: From lab to clinic Tekijä Derk Jan A. de Groot, Elisabeth G.E. de Vries, Harry J.M. Groen, Steven de Jong

    Julkaistu 2006
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    The antibody–drug conjugate target landscape across a broad range of tumour types

    The antibody–drug conjugate target landscape across a broad range of tumour types Tekijä Kirsten L. Moek, Derk Jan A. de Groot, Elisabeth G.E. de Vries, Rudolf S.N. Fehrmann

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    A review of bispecific antibodies and antibody constructs in oncology and clinical challenges

    A review of bispecific antibodies and antibody constructs in oncology and clinical challenges Tekijä Frans V. Suurs, Marjolijn N. Lub–de Hooge, Elisabeth G.E. de Vries, Derk Jan A. de Groot

    Julkaistu 2019
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Glypican 3 Overexpression across a Broad Spectrum of Tumor Types Discovered with Functional Genomic mRNA Profiling of a Large Cancer Database

    Glypican 3 Overexpression across a Broad Spectrum of Tumor Types Discovered with Functional Genomic mRNA Profiling of a Large Cancer Database Tekijä Kirsten L. Moek, Rudolf S.N. Fehrmann, Bert van der Vegt, Elisabeth G.E. de Vries, Derk Jan A. de Groot

    Julkaistu 2018
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Rapid granulomatosis with polyangiitis induced by immune checkpoint inhibition

    Rapid granulomatosis with polyangiitis induced by immune checkpoint inhibition Tekijä Rob R. H. van den Brom, Wayel H. Abdulahad, Abraham Rutgers, Bart‐Jan Kroesen, Caroline Roozendaal, Derk Jan A. de Groot, Carolien P. Schröder, Geke A.P. Hospers, Elisabeth Brouwer

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti
    Carta
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Rectal and colon cancer: Not just a different anatomic site

    Rectal and colon cancer: Not just a different anatomic site Tekijä K Tamás, Anna Maria Elisabeth Walenkamp, Elisabeth G.E. de Vries, Marcel A.T.M. van Vugt, Geerard L. Beets, Boudewijn van Etten, Derk Jan A. de Groot, Geke A.P. Hospers

    Julkaistu 2015
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Theranostics Using Antibodies and Antibody-Related Therapeutics

    Theranostics Using Antibodies and Antibody-Related Therapeutics Tekijä Kirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub–de Hooge, Adrienne H. Brouwers, Elisabeth G.E. de Vries

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Molecular imaging to support cancer immunotherapy

    Molecular imaging to support cancer immunotherapy Tekijä Pim P. van de Donk, Sjoukje F. Oosting, Daan G. Knapen, Anthonie J. van der Wekken, Adrienne H. Brouwers, Marjolijn N. Lub‐de Hooge, Derk‐Jan A. de Groot, Elisabeth G.E. de Vries

    Julkaistu 2022
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment

    Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment Tekijä Herman J. Woerdenbag, Peter Olinga, Ellen A. Kok, Donald A. P. Brugman, Ulrike F. van Ark, Arwin S. Ramcharan, Paul W. Lebbink, Frederik J.H. Hoogwater, Daan G. Knapen, Derk Jan A. de Groot, Maarten W. Nijkamp

    Julkaistu 2023
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Phase <scp>II</scp> study (<scp>KAMELEON</scp>) of single‐agent <scp>T‐DM1</scp> in patients with <scp>HER2</scp>‐positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma

    Phase <scp>II</scp> study (<scp>KAMELEON</scp>) of single‐agent <scp>T‐DM1</scp> in patients with <scp>HER2</scp>‐positive advanced urothelial bladder cancer or pancreatic cancer/c... Tekijä Elisabeth G.E. de Vries, Josef Rüschoff, Martijn P. Lolkema, Josep Tabernero, Luca Gianni, Emile E. Voest, Derk Jan A. de Groot, Daniel Castellano, Gilles Erb, Julia Naab, Margarita Donica, Regula Deurloo, Michiel S. van der Heijden, Giuseppe Viale

    Julkaistu 2023
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Molecular imaging biomarkers for immune checkpoint inhibitor therapy

    Molecular imaging biomarkers for immune checkpoint inhibitor therapy Tekijä Pim P. van de Donk, Laura Kist de Ruijter, Marjolijn N. Lub–de Hooge, Adrienne H. Brouwers, Anthonie J. van der Wekken, Sjoukje F. Oosting, Rudolf S.N. Fehrmann, Derk Jan A. de Groot, Elisabeth G.E. de Vries

    Julkaistu 2020
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    First-in-Human Study of the Biodistribution and Pharmacokinetics of 89Zr-CX-072, a Novel Immunopet Tracer Based on an Anti–PD-L1 Probody

    First-in-Human Study of the Biodistribution and Pharmacokinetics of 89Zr-CX-072, a Novel Immunopet Tracer Based on an Anti–PD-L1 Probody Tekijä Laura Kist de Ruijter, Jahlisa S. Hooiveld-Noeken, Danique Giesen, Marjolijn N. Lub‐de Hooge, Iris C. Kok, Adrienne H. Brouwers, Sjoerd G. Elias, Margaret Nguyen, Hong Lu, Jourik A. Gietema, Mathilde Jalving, Derk Jan A. de Groot, Olga Vasiljeva, Elisabeth G.E. de Vries

    Julkaistu 2021
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    89Zr-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor Uptake

    89Zr-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor Uptake Tekijä Kirsten L. Moek, Stijn J.H. Waaijer, Iris C. Kok, Frans V. Suurs, Adrienne H. Brouwers, C. Willemien Menke‐van der Houven van Oordt, Thijs T. Wind, Jourik A. Gietema, Carolien P. Schröder, Shekar V.K. Mahesh, Annelies Jorritsma‐Smit, Marjolijn N. Lub–de Hooge, Rudolf S.N. Fehrmann, Derk Jan A. de Groot, Elisabeth G.E. de Vries

    Julkaistu 2019
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer – Results of the international randomized RAPIDO-trial

    Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer – Results of the international randomized RAP... Tekijä Maxime J.M. van der Valk, Corrie A.M. Marijnen, Boudewijn van Etten, Esmée A. Dijkstra, Denise E. Hilling, Elma Meershoek‐Klein Kranenbarg, Hein Putter, Annet G.H. Roodvoets, Renu R. Bahadoer, Tone Fokstuen, Albert J. ten Tije, Jaume Capdevila, Mathijs P. Hendriks, Ibrahim Edhemović, Andrés Cervantes, Derk Jan A. de Groot, Per J. Nilsson, Bengt Glimelius, Cornelis J.�H. van de Velde, Geke A.P. Hospers

    Julkaistu 2020
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    89Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer

    89Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer Tekijä Iris C. Kok, J.S. Hooiveld, Pim P. van de Donk, Danique Giesen, Elly L. van der Veen, Marjolijn N. Lub–de Hooge, Adrienne H. Brouwers, T. Jeroen N. Hiltermann, Anthonie J. van der Wekken, Lucie B.M. Hijmering-Kappelle, Wim Timens, Sjoerd G. Elias, Geke A.P. Hospers, Harry J.M. Groen, Wilma Uyterlinde, Bernies van der Hiel, John B.A.G. Haanen, Derk Jan A. de Groot, Mathilde Jalving, Elisabeth G.E. de Vries

    Julkaistu 2021
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial

    Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial Tekijä Laura Kist de Ruijter, Pim P. van de Donk, Jahlisa S. Hooiveld-Noeken, Danique Giesen, Sjoerd G. Elias, Marjolijn N. Lub–de Hooge, Sjoukje F. Oosting, Mathilde Jalving, Wim Timens, Adrienne H. Brouwers, Thomas C. Kwee, Jourik A. Gietema, Rudolf S.N. Fehrmann, Bernard M. Fine, Sandra M. Sanabria Bohórquez, Mahesh Yadav, Hartmut Koeppen, Jing Jing, Sebastián Guelman, Mark T. Lin, Michael Mamounas, Jeffrey Eastham, Patrick K. Kimes, Simon P. Williams, Alexander Ungewickell, Derk Jan A. de Groot, Elisabeth G.E. de Vries

    Julkaistu 2022
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs

    The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs Tekijä Daphne van der Velden, Louisa R. Hoes, Hanneke van der Wijngaart, Jade M. van Berge Henegouwen, Erik van Werkhoven, Paul Roepman, Richard L. Schilsky, Wendy W.J. de Leng, Alwin D. R. Huitema, Bastiaan Nuijen, Petra M. Nederlof, Carla M.L. van Herpen, Derk Jan A. de Groot, Lot A. Devriese, Ann Hoeben, Maja J.A. de Jonge, Myriam Chalabi, Egbert F. Smit, Adrianus J. de Langen, Niven Mehra, Mariëtte Labots, Ellen Kapiteijn, Stefan Sleijfer, Edwin Cuppen, Henk M.W. Verheul, Hans Gelderblom, Emile E. Voest

    Julkaistu 2019
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trial

    Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trial Tekijä Jacob L. van Dam, Eva M. M. Verkolf, E.N. Dekker, Bert A. Bonsing, Svein Olav Bratlie, Lodewijk A.A. Brosens, Olivier R. Busch, Lydi M.J.W. van Driel, Casper H.J. van Eijck, Shirin Feshtali, Poya Ghorbani, Derk Jan A. de Groot, Jan Willem B. de Groot, Brigitte C. M. Haberkorn, Ignace H. J. T. de Hingh, Bronno van der Holt, Tom M. Karsten, M. B. van der Kolk, Knut Jørgen Labori, Mike S.L. Liem, O. J. L. Loosveld, I. Quintus Molenaar, M. Polée, Hjalmar C. van Santvoort, J. de Vos – Geelen, M. L. Wumkes, Geertjan van Tienhoven, Marjolein Y.V. Homs, Marc G. Besselink, Johanna W. Wilmink, Bas Groot Koerkamp

    Julkaistu 2023
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)

    Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases:... Tekijä Koen P. Rovers, Checca Bakkers, Geert A. Simkens, Jacobus W. A. Burger, Simon W. Nienhuijs, Geert-Jan Creemers, Anna M.J. Thijs, Alexandra R. M. Brandt‐Kerkhof, Eva V. E. Madsen, Ninos Ayez, Nadine L. de Boer, Esther van Meerten, Jurriaan B. Tuynman, Miranda Kusters, Nina R. Sluiter, Henk M.W. Verheul, Hans van Vliet, Marinus J. Wiezer, Djamila Boerma, Emma C. E. Wassenaar, Maartje Los, Cornelis B. Hunting, Arend G. J. Aalbers, Niels F.M. Kok, Koert F.D. Kuhlmann, Henk Boot, Myriam Chalabi, Schelto Kruijff, Lukas B. Been, Robert J. van Ginkel, Derk Jan A. de Groot, Rudolf S.N. Fehrmann, Johannes H.W. de Wilt, Andreas J. A. Bremers, Philip R. de Reuver, Sandra A. Radema, Karin H. Herbschleb, Wilhelmina M. U. van Grevenstein, Arjen J. Witkamp, Miriam Koopman, Nadia Haj Mohammad, Eino B. van Duyn, W. J. B. Mastboom, Leonie J. Mekenkamp, Joost Nederend, Max J. Lahaye, Pétur Snæbjörnsson, Cornelis Verhoef, Hanneke W.M. van Laarhoven, Aeilko H. Zwinderman, Jeanette M. Bouma, Onno Kranenburg, Iris van ’t Erve, Remond J.A. Fijneman, Marcel G. W. Dijkgraaf, Patrick Hemmer, Cornelis J.A. Punt, Pieter J. Tanis, Ignace H. J. T. de Hingh

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands

    Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands Tekijä Tara M. Mackay, Anouk E.J. Latenstein, Simone Augustinus, Lydia G. van der Geest, Auke Bogte, Bert A. Bonsing, Geert A. Cirkel, Lieke Hol, Olivier R. Busch, Marcel den Dulk, Lydi M.J.W. van Driel, Sebastiaan Festen, Derk‐Jan A. de Groot, Jan‐Willem B. de Groot, Bas Groot Koerkamp, Nadia Haj Mohammad, Joyce T. Haver, Erwin van der Harst, Ignace H. J. T. de Hingh, Marjolein Y.V. Homs, Maartje Los, Saskia Luelmo, Vincent E. de Meijer, Leonie J. Mekenkamp, I. Quintus Molenaar, Gijs A. Patijn, Rutger Quispel, Tessa E H Römkens, Hjalmar C. van Santvoort, Martijn W.J. Stommel, Niels G. Venneman, Robert C. Verdonk, Frederike G.I. van Vilsteren, Judith de Vos‐Geelen, C. Henri van Werkhoven, Jeanin E. van Hooft, Casper H.J. van Eijck, Johanna W. Wilmink, Hanneke W.M. van Laarhoven, Marc G. Besselink, Hendrik Bos, Koop Bosscha, Lodewijk A.A. Brosens, Geert‐Jan Creemers, Wouter L. Curvers, Sarah Derks, Susan van Dieren, Erwin J. M. van Geenen, Brigitte C. M. Haberkorn, Gerrit J. Hemmink, Chantal Hoge, Akin Inderson, Maarten Jacobs, Emile D. Kerver, Mike S.L. Liem, Hans Lubbinge, Jennifer M. J. Schreinemakers, Heidi Schut, Tom Seerden, Joanne Verheij, Annelie Vulink, Caroline Wientjes, Fennie Wit, Frank J. Wessels, Babs M. Zonderhuis

    Julkaistu 2024
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: